OTC p.Arg141Pro
c.422G>C · rs68026851 · VCV97198
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9892 | likely pathogenic ✓ concordant with ClinVar · top 5% in OTC |
|---|---|---|
| REVEL | 0.978 | strongly pathogenic-leaning |
| SaProt | LLR -13.41 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 9.8 | GERP 2.4, phastCons 1 |
| Regional constraint | o/e 0.75 | unconstrained · MANE · 68 kb · p 3.9e-05 · regional, not allelic |
| Overall | ||
| CADD | 27.9 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| East Asiangrpmax | 0.00902% | 11,081 |
| Admixed American | 0.0022% | 45,481 |
| European (non-Finnish) | 0.000113% | 886,156 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- OTC
- Protein
- p.Arg141Pro
- Coding
- c.422G>C
- MANE Select
- NM_000531
- dbSNP
- rs68026851
- Type
- single nucleotide variant
- Location
- chrX:38401310 (GRCh38)
- Structure
- AlphaFold pLDDT 91.94 · 4 PDB
- Residue 141
- a β-strand; a binding site; a UniProt-annotated variant site (in otcd); a UniProt-annotated variant site (in otcd; most common variant; loss of ornithine carbamoyltransferase activity; activity is 100-fold lower)
Disease context
ornithine carbamoyltransferase deficiency — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Ornithine transcarbamylase deficiency (Orphanet):
- Inheritance
- X-linked recessive
- Onset
- All ages
- Prevalence
- 1-9 / 100 000 (Europe)
Similar variants
- OTC p.Arg141Gln Pathogenic ★★ same residue
- OTC p.Arg141Ter Pathogenic ★ same residue
- OTC p.Arg141= Likely benign ★ same residue
- OTC p.Arg141Gly Pathogenic ★ same residue
- OTC c.298+2T>G Pathogenic ★★ same condition
- OTC c.299-1G>A Likely pathogenic ★★ same condition
- OTC c.386+1G>A Pathogenic ★★ same condition
- OTC c.540+1G>A Pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/otc-p-arg141pro (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown